Circ Arrhythm Electrophysiol

Slides:

Advertisements

Similar presentations

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial by Atul Verma, Roberto Mantovan,

Advertisements

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Obstructive Sleep Apnea Treatment on Atrial.

Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.

Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation by Laurens F. Tops, Martin.

Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial.

Volume 12, Issue 7, Pages (July 2015)

Circ Arrhythm Electrophysiol

Rationale and design of the FreezeAF trial: A randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon.

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Date of download: 11/9/2017 Copyright © ASME. All rights reserved.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Up to 6-year follow-up after pulmonary vein isolation for persistent/permanent atrial fibrillation: Importance of sinus node function Yoshiharu Soga,

Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol

Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial Fibrillation by Martin R. Karch, Bernhard Zrenner, Isabel Deisenhofer, Jürgen Schreieck,

Circ Arrhythm Electrophysiol

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Circ Arrhythm Electrophysiol

Circ Arrhythm Electrophysiol

Dynamically Shaped Magnetic FieldsClinical Perspective

Targets and End Points in Cardiac Autonomic Denervation Procedures

Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated CardiomyopathyClinical Perspective by Diane Fatkin, Thomas.

Circ Arrhythm Electrophysiol

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Circ Arrhythm Electrophysiol

Modest Increase in Peak VO2 Is Related to Better Clinical Outcomes in Chronic Heart Failure PatientsClinical Perspective by Ann M. Swank, John Horton,

Circ Arrhythm Electrophysiol

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Contribution of Stroke to the Cochrane Stroke Group Trials Register

Slowing of ventricular rate (VR) associated with inferior vena cava–inferior atrial ganglionated plexus nerve activity (IVC-IAGPNA) discharge without right.

Circ Arrhythm Electrophysiol

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

The Process of Rehabilitation and Discharge Planning in Stroke

Optimal Pacing for Right Ventricular and Biventricular Devices

Where does atrial fibrillation surgery fail

Volume 12, Issue 5, Pages (May 2015)

(p for noninferiority = )

MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.

Waddah Maskoun et al. JACEP 2016;2:

Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation—results of 5 years of follow-up Qiu-Ming.

The Outcome of the Cox Maze Procedure in Patients With Previous Percutaneous Catheter Ablation to Treat Atrial Fibrillation Niv Ad, MD, Linda Henry,

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 14, Issue 5, Pages (May 2017)

AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.

Volume 12, Issue 9, Pages (September 2015)

James R. Edgerton, MD, Cecile Mahoney, BS, Michael J

Junaid A.B. Zaman et al. JACEP 2017;3:

Risk Factor Modification

Catheter Ablation for Atrial Fibrillation

Amir Jadidi et al. JACEP 2018;4:

Stavros Stavrakis et al. JACEP 2015;1:1-13

Patrick T. O'Gara, MD, MACC, FAHA, Thoralf M. Sundt, MD, Michael A

The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.

K.R. Julian Chun et al. JACEP 2017;3:

Atrial fibrillation originating from recipient left atrium after an orthotopic heart transplantation Auroa Badin, MD, Jaret Tyler, MD, FHRS, Steven J.

Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? John M. Stulak,

Volume 14, Issue 9, Pages (September 2017)

Volume 13, Issue 12, Pages (December 2016)

Volume 8, Issue 3, Pages (March 2011)

Gijs E. de Maat, MD, Hendyke Z. R. Gerds-Ploeger, NP, Massimo A

Arrhythmia surgery for atrial fibrillation associated with atrial septal defect: Right-sided maze versus biatrial maze Yu-Mi Im, MS, Joon Bum Kim, MD,

Meta-analysis of risk ratios for percentage of patients who developed catheter-associated urinary tract infection, for intervention versus control groups,

Simple surgical isolation of pulmonary veins for treating secondary atrial fibrillation in mitral valve disease1 Renato A.K Kalil, MD, PhD, Gustavo G.

Forest plot of all-cause mortality (ACM) in CRT patient with AF comparing atrioventricular junction ablation (AVJA) versus no AVJA. AF, atrial fibrillation;

Temporal trends of AF hospitalisation per 100 patients with AF according to main hospitalisation causes between 2006 and *P value for increase trends

This section, cut in the frontal plane, in a human embryo at Carnegie stage 16, shows the entry of the pulmonary vein to the inferior aspect of the left.

Presentation transcript:

Circ Arrhythm Electrophysiol Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCLINICAL PERSPECTIVE by Jonathan P. Piccini, Renato D. Lopes, Melissa H. Kong, Vic Hasselblad, Kevin Jackson, and Sana M. Al-Khatib Circ Arrhythm Electrophysiol Volume 2(6):626-633 December 1, 2009 Copyright © American Heart Association, Inc. All rights reserved.

Figure 1. QUOROM algorithm. Jonathan P. Piccini et al. Circ Arrhythm Electrophysiol. 2009;2:626-633 Copyright © American Heart Association, Inc. All rights reserved.

Figure 2. ORs (ablation versus control) for freedom from atrial fibrillation at 12 months. Jonathan P. Piccini et al. Circ Arrhythm Electrophysiol. 2009;2:626-633 Copyright © American Heart Association, Inc. All rights reserved.

Figure 3. Rate ratios (ablation versus control) for hospitalization for cardiovascular causes per patient-years. Figure 3. Rate ratios (ablation versus control) for hospitalization for cardiovascular causes per patient-years. Jonathan P. Piccini et al. Circ Arrhythm Electrophysiol. 2009;2:626-633 Copyright © American Heart Association, Inc. All rights reserved.

Figure 4. Incidence of repeat PVI or crossover in the first year of follow-up. Figure 4. Incidence of repeat PVI or crossover in the first year of follow-up. Vertical bars show the percentage of patients who underwent repeat PVI or crossed over to catheter ablation in each study. Krittayaphong et al did not report repeat PVI or crossover data. In Wazni et al, the protocol discouraged crossover to PVI during the trial; however, 4 of 32 patients underwent repeat PVI after the 12-month study. Jonathan P. Piccini et al. Circ Arrhythm Electrophysiol. 2009;2:626-633 Copyright © American Heart Association, Inc. All rights reserved.